Alliance Foundation Trials launches PATINA phase 3 trial of CDK 4/6 inhibitor palbociclib to treat HR+, HER2+ metastatic breast cancer
The Alliance Foundation Trials, LLC (AFT), in conjunction with Pfizer and six international cancer research groups, announced the launch of PATINA a randomized, openlabel, phase 3 clinical study of the cyclindependent kinase24-08-2017